Glomosafe Tablet is a pharmaceutical formulation combining Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and promote antioxidant defense mechanisms. Taurine, a sulfur-containing amino acid, plays a crucial role in osmoregulation, membrane stabilization, and modulation of calcium signaling, contributing to cardiovascular and neurological function. Acetylcysteine, a well-known mucolytic agent and precursor to glutathione, enhances the body’s antioxidant capacity by replenishing intracellular glutathione stores, thereby mitigating oxidative stress and supporting detoxification processes. The synergistic action of Taurine and Acetylcysteine in Glomosafe Tablet aids in protecting cells from damage induced by free radicals and oxidative injury, which is beneficial in conditions associated with oxidative stress and impaired cellular metabolism. This combination may be indicated as an adjunctive therapy in chronic respiratory disorders, liver dysfunction, and metabolic syndromes where antioxidant support is warranted. Glomosafe Tablet should be administered under medical supervision, with dosage adjusted according to individual patient needs and clinical response. Caution is advised in patients with hypersensitivity to the components or underlying medical conditions. Regular monitoring is recommended to assess therapeutic efficacy and detect any adverse reactions.